Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2400817 | 0.98 | MAOB (0.75) | MAOBACHE | |
| SCHEMBL13590254 | 0.95 | ACHE (0.73) | MAOBACHE | |
| SCHEMBL14729859 | 0.95 | MAOB (0.77) | MAOBACHE | |
| SCHEMBL25443484 | 0.93 | MAOB (0.74) | MAOBACHE | |
| SCHEMBL25443471 | 0.93 | MAOB (0.74) | MAOBACHE | |
| SCHEMBL13590077 | 0.91 | ACHE (0.68) | MAOBACHE | |
| SCHEMBL4916280 | 0.89 | MAOB (0.68) | MAOBACHE | |
| SCHEMBL29263614 | 0.88 | ACHE (0.68) | MAOBACHE | |
| SCHEMBL4606466 | 0.88 | MAOB (1.00) | MAOBACHE | |
| SCHEMBL16306674 | 0.87 | MAOB (0.67) | MAOBACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8017637-B2 | Inhibitors of cdc phosphatases | IPSEN PHARMA S.A.S. (FR) | 2011-09-13 | — | — | US | disclosed |
| US-20090275624-A1 | INHIBITORS OF CDC PHOSPHATASES | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 2009-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090275624-A1 | INHIBITORS OF CDC PHOSPHATASES | CDC25C, CDC25A, CDC25B | MAOB 3885/4885ACHE 4794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.